The COVID-19 pandemic demonstrated that scientific discovery can move at extraordinary speed, but it also expose...
Singapore has launched a new Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) laboratory near Changi ...
Francesca Ceddia, Chief Medical Affairs Officer, Moderna (Left) Dr Leong Hoe Nam, Infectious Disease Specialist, Moun...
A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...
Daiichi Sankyo has reached an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to supply the o...
Scientists led by a team from Duke-NUS Medical School in Singapore have identified three distinct serotypes of SARS-rela...
Exceptionally potent antibodies that can neutralise virtually all known variants of the COVID-19 virus—including O...
CSPC Pharmaceutical Group has signed a strategic partnership agreement with American pharma firm Pfizer to la...
South Korea-based SK bioscience has received the World Health Organisation (WHO) Emergency Use Listing (EUL) of its COVI...
Researchers at The University of Queensland (UQ) in Australia have discovered viruses such as SARS-CoV-2 can cause brain...
SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...
The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...
Chugai Pharma Taiwan Ltd., a wholly-owned subsidiary of Japan's Chugai Pharmaceutical, has obtained an import drug licen...
The Australian Government will provide a further $50 million from the Medical Research Future Fund (MRFF) for research i...
The Central Epidemic Command Center (CECC) in Taiwan has reported that the Advisory Committee on Immunisation Practices ...
New Zealand (NZ)-based startup Pictor, with operations in US and India, has announced a funding round to help accelerate...
CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...
The Health Sciences Authority (HSA) has authorised Pfizer’s Comirnaty COVID-19 vaccine on 28 September 2022, for t...
On September 19, 2022, Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health, Dr Satit Pitutecha, Dep...
Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quanti...
Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...
Pfizer has been ranked first in its COVID-19 response, patient centricity, patient safety and bringing innovative, high-...
The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Moderna’s Spikevax COVI...
Australia-based Antisense Therapeutics has announced the outcomes from its collaboration to study the neurological aspec...
